Literature DB >> 3384943

Aluminum inhibits erythropoiesis in vitro.

J Mladenovic1.   

Abstract

Anemia has been associated with aluminum intoxication in patients on chronic dialysis and in animals. In studies presented here, in vitro human erythroid culture was used to delineate the effects of aluminum on normal hematopoiesis. Aluminum by itself in routine culture, even at very high levels (1,035 ng/ml), did not significantly affect erythroid colony growth. The addition of human transferrin to the culture, however, resulted in a marked dose-dependent inhibition of erythroid, but not myeloid colony growth. At all doses, CFU-E progenitors showed greater inhibition than burst-forming units (BFU-E). Aluminum inhibition was not overcome by increasing the dose of erythropoietin or adding additional burst-promoting activity to the culture. Inhibition by aluminum was directly related to the number of binding sites on transferrin in the culture, and was not observed in the presence of fully iron-saturated transferrin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3384943      PMCID: PMC442607          DOI: 10.1172/JCI113502

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  The effect of pH upon human transferrin: selective labelling of the two iron-binding sites.

Authors:  A N Lestas
Journal:  Br J Haematol       Date:  1976-03       Impact factor: 6.998

2.  The dialysis encephalopathy syndrome. Possible aluminum intoxication.

Authors:  A C Alfrey; G R LeGendre; W D Kaehny
Journal:  N Engl J Med       Date:  1976-01-22       Impact factor: 91.245

3.  The inhibition of ferroxidase by trivalent and other metal ions.

Authors:  C T Huber; E Frieden
Journal:  J Biol Chem       Date:  1970-08-10       Impact factor: 5.157

4.  Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis.

Authors:  A C Alfrey; J M Mishell; J Burks; S R Contiguglia; H Rudolph; E Lewin; J H Holmes
Journal:  Trans Am Soc Artif Intern Organs       Date:  1972

5.  Dialysis encephalopathy: recovery after interruption of aluminium intake.

Authors:  M Poisson; R Mashaly; B Lebkiri
Journal:  Br Med J       Date:  1978-12-09

6.  Iron-donating properties of transferrin.

Authors:  D C Harris; P Aisen
Journal:  Biochemistry       Date:  1975-01-28       Impact factor: 3.162

7.  Aluminium studies in dialysis encephalopathy.

Authors:  H L Elliott; A I Macdougall
Journal:  Proc Eur Dial Transplant Assoc       Date:  1978

8.  Removal of transferrin from fetal bovine serum.

Authors:  E Huebers; N J Nelson; H A Huebers; J S Rasey
Journal:  J Lab Clin Med       Date:  1987-12

9.  Effects of aluminium, lead and zinc on delta-aminolaevulinic acid dehydratase.

Authors:  P A Meredith; M R Moore; A Goldberg
Journal:  Enzyme       Date:  1977

10.  Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium.

Authors:  M K Ward; T G Feest; H A Ellis; I S Parkinson; D N Kerr
Journal:  Lancet       Date:  1978-04-22       Impact factor: 79.321

View more
  6 in total

1.  Effect of aluminium on iron uptake and transferrin-receptor expression by human erythroleukaemia K562 cells.

Authors:  S J McGregor; M L Naves; R Oria; J K Vass; J H Brock
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

Review 2.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

3.  Aluminum effect on the activity of superoxide dismutase and of other antioxygenic enzymes in vitro.

Authors:  M A Serra; V Barassi; C Canavese; E Sabbioni
Journal:  Biol Trace Elem Res       Date:  1991-10       Impact factor: 3.738

Review 4.  [Aluminum toxicity].

Authors:  H V Henning
Journal:  Klin Wochenschr       Date:  1989-12-15

5.  Heme oxygenase induction. A possible factor in aluminum-associated anemia.

Authors:  B Fulton; E H Jeffery
Journal:  Biol Trace Elem Res       Date:  1994-01       Impact factor: 3.738

6.  Resistance to recombinant human erythropoietin due to aluminium overload and its reversal by low dose desferrioxamine therapy.

Authors:  M Yaqoob; R Ahmad; P McClelland; K A Shivakumar; D F Sallomi; I H Fahal; N B Roberts; T Helliwell
Journal:  Postgrad Med J       Date:  1993-02       Impact factor: 2.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.